AAAAAA

   
Results: 1-23 |
Results: 23
A second case of Hb Renert [beta 133(H11)Val -> Ala]
Authors: Wilson, G Forrest, P Heppinstall, S Green, BN Goodeve, AC Peake, IR Reilly, JT Porter, N Rees, DC
Citation: G. Wilson et al., A second case of Hb Renert [beta 133(H11)Val -> Ala], HEMOGLOBIN, 25(3), 2001, pp. 337-340
Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study
Authors: Barnett, D Goodfellow, K Ginnever, J Granger, V Whitby, L Reilly, JT
Citation: D. Barnett et al., Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study, CLIN LAB H, 23(1), 2001, pp. 43-51
Affordable CD4(+) T cell counts by flow cytometry II. The use of fixed whole blood in resource-poor settings
Authors: Jani, IV Janossy, G Iqbal, A Mhalu, FS Lyamuya, EF Biberfeld, G Glencross, DK Scott, L Reilly, JT Granger, V Barnett, D
Citation: Iv. Jani et al., Affordable CD4(+) T cell counts by flow cytometry II. The use of fixed whole blood in resource-poor settings, J IMMUNOL M, 257(1-2), 2001, pp. 145-154
UKNEQAS for leucocyte immunophenotyping: the first 10 years
Authors: Reilly, JT Barnett, D
Citation: Jt. Reilly et D. Barnett, UKNEQAS for leucocyte immunophenotyping: the first 10 years, J CLIN PATH, 54(7), 2001, pp. 508-511
Untitled
Authors: Hann, IM Cotter, FE Reilly, JT
Citation: Im. Hann et al., Untitled, BR J HAEM, 114(1), 2001, pp. 1-1
Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia
Authors: Abu-Duhier, FM Goodeve, AC Wilson, GA Care, RS Peake, IR Reilly, JT
Citation: Fm. Abu-duhier et al., Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia, BR J HAEM, 113(4), 2001, pp. 983-988
Genomic structure of human FLT3: Implications for mutational analysis
Authors: Abu-Duhier, FM Goodeve, AC Wilson, GA Care, RS Peake, IR Reilly, JT
Citation: Fm. Abu-duhier et al., Genomic structure of human FLT3: Implications for mutational analysis, BR J HAEM, 113(4), 2001, pp. 1076-1077
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients
Authors: Matutes, E Taylor, GP Cavenagh, J Pagliuca, A Bareford, D Domingo, A Hamblin, R Kelsey, S Mir, N Reilly, JT
Citation: E. Matutes et al., Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients, BR J HAEM, 113(3), 2001, pp. 779-784
Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14
Authors: Sinclair, EJ Forrest, EC Reilly, JT Watmore, AE Potter, AM
Citation: Ej. Sinclair et al., Fluorescence in situ hybridization analysis of 25 cases of idiopathic myelofibrosis and two cases of secondary myelofibrosis: monoallelic loss of RB1, D13S319 and D13S25 loci associated with cytogenetic deletion and translocation involving 13q14, BR J HAEM, 113(2), 2001, pp. 365-368
Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia
Authors: Charles, KS Kanaa, M Winfield, DW Reilly, JT
Citation: Ks. Charles et al., Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia, CLIN LAB H, 22(3), 2000, pp. 171-174
Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders
Authors: Leach, M Parsons, RM Reilly, JT Winfield, DA
Citation: M. Leach et al., Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders, CLIN LAB H, 22(3), 2000, pp. 175-178
Standardization of lymphocyte antibody binding capacity - a multi-centre study
Authors: Barnett, DD Storie, I Granger, V Whitby, L Reilly, JT Brough, S Garner, S Lawry, J Richards, S Bell, AE Shenton, BK
Citation: Dd. Barnett et al., Standardization of lymphocyte antibody binding capacity - a multi-centre study, CLIN LAB H, 22(2), 2000, pp. 89-96
Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia
Authors: Rowe, D Cotterill, SJ Ross, FM Bunyan, DJ Vickers, SJ Bryon, J McMullan, DJ Griffiths, MJ Reilly, JT Vandenberghe, EA Wilson, G Watmore, AE Bown, NP
Citation: D. Rowe et al., Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia, BR J HAEM, 111(4), 2000, pp. 1051-1056
Are aberrant BCR-ABL transcripts more common than previously thought?
Authors: Wilson, GA Vandenberghe, EA Pollitt, RC Rees, DC Goodeve, AC Peake, IR Reilly, JT
Citation: Ga. Wilson et al., Are aberrant BCR-ABL transcripts more common than previously thought?, BR J HAEM, 111(4), 2000, pp. 1109-1111
FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group
Authors: Abu-Duhier, FM Goodeve, AC Wilson, GA Gari, MA Peake, IR Rees, DC Vandenberghe, EA Winship, PR Reilly, JT
Citation: Fm. Abu-duhier et al., FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group, BR J HAEM, 111(1), 2000, pp. 190-195
Reduction of intra- and interlaboratory variation in CD34(+) stem cell enumeration using stable test material, standard protocols and targeted training
Authors: Barnett, D Granger, V Kraan, J Whitby, L Reilly, JT Papa, S Gratama, JW
Citation: D. Barnett et al., Reduction of intra- and interlaboratory variation in CD34(+) stem cell enumeration using stable test material, standard protocols and targeted training, BR J HAEM, 108(4), 2000, pp. 784-792
The estimation of fetomaternal haemorrhage
Authors: Kelsey, P Reilly, JT Chapman, JF Bain, BJ Bates, SC Knowles, SM Shwe, KH Parker-Williams, J Robson, L Robson, SC Bruce, M Duguid, J Murphy, MF Williamson, L Cavill, I Wood, JK Amos, RJ Hyde, K Matutes, E
Citation: P. Kelsey et al., The estimation of fetomaternal haemorrhage, TRANSFUS M, 9(1), 1999, pp. 87-92
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
Authors: Michiels, JJ Kutti, J Stark, P Bazzan, M Gugliotta, L Marchioli, R Griesshammer, M van Genderen, PJJ Briere, J Kiladjian, JJ Barbui, T Finazzi, G Berlin, NI Pearson, TC Green, AC Fruchtmann, SM Silver, RT Hansmann, E Wehmeier, A Lengfelder, E Landolfi, R Kvasnicka, HM Hasselbalch, H Cervantes, F Reilly, JT Demory, JL Gisslinger, H Guardiola, P Martyre, MC Le Bousse-Kerdiles, MC Thiele, J
Citation: Jj. Michiels et al., Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis, NETH J MED, 54(2), 1999, pp. 46-62
Guideline for the flow cytometric enumeration of CD34(+) haematopoietic stem cells
Authors: Barnett, D Janossy, G Lubenko, A Matutes, E Newland, A Reilly, JT
Citation: D. Barnett et al., Guideline for the flow cytometric enumeration of CD34(+) haematopoietic stem cells, CLIN LAB H, 21(5), 1999, pp. 301-308
Absolute CD4(+) T-lymphocyte and CD34(+) stem cell counts by single-platform flow cytometry: the way forward
Authors: Barnett, D Granger, V Whitby, L Storie, I Reilly, JT
Citation: D. Barnett et al., Absolute CD4(+) T-lymphocyte and CD34(+) stem cell counts by single-platform flow cytometry: the way forward, BR J HAEM, 106(4), 1999, pp. 1059-1062
The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia
Authors: Pearson, TC Bareford, D Craig, J Egan, EL Green, AR Lucas, GS Ludlam, CA McMullin, MF Messinezy, M Oscier, DG Reilly, JT
Citation: Tc. Pearson et al., The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia, BR J HAEM, 106(3), 1999, pp. 833-834
Axillary odor determination, formation, and control
Authors: Labows, JN Reilly, JT Leyden, JJ Preti, G
Citation: Jn. Labows et al., Axillary odor determination, formation, and control, COSMETIC SC, 20, 1999, pp. 59-82
Pathogenesis and management of idiopathic myelofibrosis
Authors: Reilly, JT
Citation: Jt. Reilly, Pathogenesis and management of idiopathic myelofibrosis, BAIL CLIN H, 11(4), 1998, pp. 751-767
Risultati: 1-23 |